The burden of pertussis in older adults: what is the role of vaccination? A systematic literature review

W Kandeil, P Atanasov, D Avramioti, J Fu… - Expert review of …, 2019 - Taylor & Francis
Introduction: Pertussis (whooping cough) is a vaccine-preventable disease; however,
neither natural-nor vaccine-induced protection is life-long. Although generally not severe in …

Combination vaccines

MD Decker - Primary Care: Clinics in Office Practice, 2001 - primarycare.theclinics.com
The present rapid growth in the availability of safe and effective vaccines provides a
continuing need to expand and simplify vaccine administration programs. The replacement …

[HTML][HTML] Use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines: updated recommendations of the Advisory Committee on Immunization …

FP Havers - MMWR. Morbidity and mortality weekly report, 2020 - cdc.gov
Background Two Tdap vaccines are licensed for use in the United States. Boostrix
(GlaxoSmithKline) is approved for a single dose in persons aged≥ 10 years; Adacel (Sanofi …

[HTML][HTML] Recommendations for adult immunization by the Korean Society of Infectious Diseases, 2023: minor revisions to the 3rd edition

WS Choi, JY Song, KT Kwon, HJ Lee… - Infection & …, 2024 - ncbi.nlm.nih.gov
Abstract The Korean Society of Infectious Diseases has been regularly developing
guidelines for adult immunization since 2007. In 2023, the guidelines for the following seven …

Age and primary vaccination background influence the plasma cell response to pertussis booster vaccination

AM Diks, P Versteegen, C Teodosio, RJ Groenland… - Vaccines, 2022 - mdpi.com
Pertussis is a vaccine-preventable disease caused by the bacterium Bordetella pertussis.
Over the past years, the incidence and mortality of pertussis increased significantly. A …

Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults

J Mertsola, O Van Der Meeren, Q He… - Clinical infectious …, 2010 - academic.oup.com
Background. Booster vaccination against tetanus and diphtheria at 10-year intervals is
commonly recommended. Reduced antigen content diphtheria and tetanus toxoids and …

Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix®): results of two randomized …

WM Weston, LR Friedland, X Wu, B Howe - Vaccine, 2012 - Elsevier
BACKGROUND: Pertussis can cause significant morbidity in elderly patients, who can also
transmit this disease to infants and young children. There is little data available on the use of …

Characterization of an age-response relationship to GSK's recombinant hepatitis B vaccine in healthy adults: an integrated analysis

O Van Der Meeren, P Crasta, B Cheuvart… - Human vaccines & …, 2015 - Taylor & Francis
The immune system becomes less effective with age, and older age is associated with an
increased susceptibility to diseases and reduced responses to vaccination. Furthermore …

Vaccination in the elderly: what can be recommended?

PO Lang, R Aspinall - Drugs & aging, 2014 - Springer
The age-associated increased susceptibility to infectious disease would suggest that
vaccination should be a route to promote healthy aging and keep our seniors autonomous …

Immunogenicity and safety of a quadrivalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (MenACWY-TT) administered to adults …

G Dbaibo, N El-Ayoubi, S Ghanem, F Hajar, V Bianco… - Drugs & aging, 2013 - Springer
Background The burden of invasive meningococcal disease is substantial in older adults in
whom the case fatality rate is high. Travelers to regions with high rates of meningococcal …